Abstract: A method and apparatus for printing images wherein printing of individual dots is controlled by employing binary masks. M different complementary binary masks each having the form of a matrix of points occupying N rows and P columns are defined in such a manner that each of the N.times.P elements of a mask has a first binary value or a second binary value, each point of the matrix corresponding to an element having the first binary value in one mask and in one mask only. Each portion of the image is printed in M passes of the print head while using the M different masks in succession, such that during each pass, the print head scans a strip of the print medium, the same mask being used repetitively for each group of P columns and N rows, an image dot being released for printing during a pass when the corresponding element of the mask has the first binary value.

Abstract: The present invention is directed to a method for reliably determining lymph nodes enriched in tumor reactive cells, e.g., CD4+tumor-specific lymphocytes. This method includes the steps of administering to a patient an effective amount of a radiolabeled locator which specifically binds a marker produced by or associated with neoplastic tissue. Time is permitted to elapse following the administration for the radiolabeled locator to preferentially concentrate in any neoplastic tissue and for unbound radiolabeled locator to be cleared, so as to increase the ratio of photon emissions from neoplastic tissue to background photon emissions in the patient. After the time has elapsed, the patient is accessed with a radiation detection probe for determining lymph node sites exhibiting accretion of the radiolabeled locator by detecting with the probe elevated levels of radiation at the lymph node sites.

Abstract: In a ball-type joint, the directrix lines (16B) of the grooves (12) of the hub element (3) are defined in such a manner as to provide a groove depth which only slightly varies. The directrix lines (14B) of the grooves (9) of the bell elements are deduced by symmetry relative to a bisecting plane (P) of the joint.

Abstract: An electron multiplier of the perforated sheet type includes two successive sheets constituting a dynode which has several multiplier channels in common. For controlling the gain of a given channel (A), a control electrode (30) is provided in the form of a sheet inserted between the sheets (14, 15) of a dynode (Dn) which has a grating window (33) controlling the gain of the channel (A) in question, and one (or several) aperture(s) (34) in accordance with the number of remaining channels. Another channel (B) is controlled by another electrode (31) inserted between the sheets (16, 17) of another dynode (D.sub.n+1). Also disclosed is a multi-channel photomultiplier tube which includes such an electron multiplier.

Abstract: In a fishing reel with an instantaneously disengageable non-return device, the non-return device has teeth on the inside face of the line recovery device drum. A pawl pivots about an offset spindle on the reel frame and engages with the teeth on the drum in a locked position. A lever pivoting about the main axis of the reel is friction driven by the drum and in turn drives the pawl. The coupling area of the pawl is near the rotation spindle of the pawl and away from the main axis of the reel, so that there is a large multiplication ratio between rotation of the lever and rotation of the pawl. The pawl can therefore be locked to the teeth after imperceptible rotation of the lever and the drum. This achieves an instantaneous non-return function of the drum.

Abstract: Disclosed herein are compounds of formula 1 ##STR1## wherein X is a terminal group, for example, an aryloxycarbonyl, an alkanoyl or an optionally mono- or disubstituted carbamoyl; B is absent or an amino acid residue, for example, Val or Ash; R.sup.1 is hydrogen or a ring substituent, for example, fluoro or methyl; R.sup.2 is alkyl; and Y is a ring substituent, for example, phenoxy, 2-pyridinylmethoxy, phenylthio or 2-pyridinylthio. The compounds inhibit the activity of human immunodeficiency virus (HIV) protease and interfere with HIV induced cytopathogenic effects in human cells. These properties render the compounds useful for combating HIV infections.

Abstract: A segmented photomultiplier tube having an electrode which, in its higher part acts as a focusing electrode for distributing photo-electrons on both sides of an axial plane, while in its lower part forming a collection cage, the photo-electrons undergo a first multiplication at the portions of the lateral walls, which are folded towards the axial plane. Apertures in a median plate of the electrode are covered by a highly transparent grid. The electrode is completed by a central partition which extends along the median plate just to the proximity of an input dynode of a laminated multiplier. A bar having a small cross-section may be provided, centered on the axial plane and receiving a potential near the potential across the photocathode. A plurality of these tubes can be arranged in a mosaic pattern for mapping luminous events.

Abstract: Disclosed herein are peptide derivatives of the formula A-B-D-CH.sub.2 CH{CH.sub.2 C(O)R.sup.1 }C(O)-NHCH{CR.sup.2 (R.sup.3)COOH}C(O)-E wherein A is a terminal group, for example an optionally substituted phenylalkanoyl, and B is a N-methyl amino acid residue; or A and B together form a saturated or unsaturated alkylaminocarbonyl; D is an amino acid residue; R.sup.1 is alkyl, cycloalkyl, a monosubstituted or a disubstituted amino; R.sup.2 is hydrogen or alkyl and R.sup.3 is alkyl, or R.sup.2 is hydrogen and R.sup.3 is phenylalkyl, or R.sup.2 and R.sup.3 are joined to form a cycloalkyl; and E is a terminal unit, for example, an alkylamino or a monovalent amino acid radical such as NHCH(alkyl)C(O)OH. The derivatives are useful for treating herpes infections.

Abstract: Disclosed herein are compounds of formula 1 ##STR1## wherein X is a terminal group, for example, an aryloxycarbonyl or an alkanoyl; B is absent or an amino acid residue, for example, Val or Asn; R.sup.1 is alkyl; and Y is a ring substituent, for example, benzyl, benzyloxy, phenylthio or 2-pyridinylthio. The compounds inhibit the activity of human immunodeficiency virus (HIV) protease and interfere with HIV induced cytopathogenic effects in human cells. These properties render the compounds useful for combating HIV infections.

Abstract: Disclosed herein is a stereospecific synthesis amenable to the large scale preparation of a hydrochloric acid addition salt of a chlorohydrin of the formula ##STR1## wherein R.sup.1 and R.sup.2 are amino protective groups and R.sup.3 is an amino acid side chain or a protected amino acid side chain. The synthesis involves reacting an aldehyde of the formula ##STR2## wherein R.sup.1, R.sup.2 and R.sup.3 are as defined hereinbefore with (chloromethyl)lithium at -20.degree. C. or below and contacting the resulting diastereoisomeric mixture of lithium alcoholates with aqueous hydrochloric acid to obtain a separable mixture of the hydrochloric acid addition salts of the chlorohydrin and its corresponding hydroxy diastereoisomer. The hydrochloric acid addition salt of the chlorohydrin is transformed readily into corresponding optionally amino-protected aminoepoxides; for example, 3(S)-(tert-butyloxycarbonylamino)-l,2(S)-epoxy-4-phenyl-butane.

Abstract: Disclosed herein are compounds which inhibit human immunodeficiency virus (HIV) protease activity and inhibit HIV replication in human cells. Thus, the compounds are indicated for the treatment of HIV infections. The compounds can be represented by the formula ##STR1## wherein X is a terminal group, for example, an aryloxycarbonyl, an alkanoyl or an arylalkyl carbamoyl; A is absent or an amino acid or a derived amino acid; either R.sup.1 or R.sup.2 is hydrogen while the other is alkyl or R.sup.1 and R.sup.2 are joined to form a cyclohexane; Q is hydrogen, hydroxy, halo or lower alkoxy; and Y is a terminal group, for example, an alkylamino, alkoxy or an optionally substituted anilino.

Abstract: A pharmaceutical composition suitable for administration to human beings for suppressing the production of factor VIII inhibitor includes:an immune complex of factor VIII antigen component and factor VIII inhibitor component, the components being present in a ratio such that the inhibitor blocks essentially all relevant binding sites of the antigen; anda pharmacologically acceptable carrier or diluent. The invention also provides a method of administering the compositions to suppress the production of inhibitor to factor VIII.

Abstract: The present invention relates to thrust reversers with doors for jet aircraft engines. The door (2) is equipped, on the internal face of its upstream end, with at least one auxiliary flap (8) articulated to the door and capable of being brought from a position away from the internal face of the door into a position against the latter, and locked in each of these positions by virtue of a control system with link rods (12, 17, 21, 19). The control system is actuated by virtue of its interaction with a stationary stop piece (23). Locking the flap (8) in each of its positions prevents vibration, and damage thereto.

Abstract: Assembly for a rotor whose disk alternately bears vanes (1) and platforms (2). The plays (i.e. clearances) (7) are filled up with linings (15) composed of a mainly flexible casing (16) occupied by a small rod (20) which moves outwardly under the action of the centrifugal forces for filling up the play (7).

Abstract: Disclosed herein are pentapeptide derivatives of the formula X--NR.sup.1 --CH(R.sup.2)--C(W)--NH--CR.sup.3 (R.sup.4)--C(W.sup.2)--NR.sup.5 --CH CH.sub.2 C(O)--Y!--C(W.sup.3)--NH--CR.sup.6 -- CR.sup.7 (R.sup.8)--COOH!--C(W.sup.4)--NH--CR.sup.9 (R.sup.10)--Z wherein X is a terminal group, for example, alkanoyl or phenylalkanoyl radicals, R.sup.1 is hydrogen, alkyl or phenylalkyl, R.sup.2, R.sup.4 and R.sup.10 are selected from amino acid or derived amino acid residues, R.sup.3, R.sup.5, R.sup.6, R.sup.7, R.sup.8 and R.sup.9 are hydrogen or alkyl or R.sup.7 and R.sup.8 are joined to form a cycloalkyl, W.sup.1, W.sup.2, W.sup.3 and W.sup.4 are oxo or thioxo, Y is, for example, an alkoxy or a mono or disubstituted amino, and Z is a terminal group, for example, COOH or CH.sub.2 OH. The derivatives are useful for treating herpes infections.

Abstract: A new method for sealing off a mass of waste which comprises surrounding the mass of waste, stabilized waste or its placement side with a least one substantially continuous layer of porous material, the layer defining a substantially continuous, waste-encompassing interface, and providing a sufficient amount of an interactive reagent on either side of the interface for the reagent upon placement to diffuse towards each other and to form a precipitate filling the pores of the porous material substantially along the interface thereby forming a waste-encompassing layer of reduced permeability. The special benefit of this method is that after a rupture of the seal the interactive reagents form a new seal, thus preventing loss of noxious substances through the rupture.

Abstract: A method for protecting prostheses and temporarily or permanently implantable materials from bacterial colonization and infection, wherein the material is successively impregnated with: (a) a biguanide solution having the general formula (I) ##STR1## wherein R.sub.1 is an alkyl, aminoalkyl, optionally substituted phenyl, naphthyl or cyano radical, R.sub.2 is a hydrogen atom or an alkyl radical and n is an integer from 1-6, with the proviso that the alkyl radicals and portions are linear or branched and contain 1-4 carbon atoms; and (b) a solution of an antibacterial agent which may be gradually redistributed in an aqueous medium; whereafter the material thereby impregnated is dried.